Molecules 2013, 18(5), 5251-5264; doi:10.3390/molecules18055251
Article

Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells

1 Centro de Química Estrutural, Instituto Superior Técnico, Universidade Técnica de Lisboa, 1049-001 Lisboa, Portugal 2 Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal 3 CBIOS, Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisboa, Portugal
* Author to whom correspondence should be addressed.
Received: 18 March 2013; in revised form: 4 April 2013 / Accepted: 25 April 2013 / Published: 8 May 2013
(This article belongs to the Special Issue Selenium and Tellurium Chemistry)
PDF Full-text Download PDF Full-Text [655 KB, uploaded 8 May 2013 09:35 CEST]
Abstract: We report the development of a new microwave-based synthetic methodology mediated by Woollins’ reagent that allowed an efficient conversion of caffeine into 6-selenocaffeine. A preliminary evaluation on the modulation of antioxidant activity upon selenation of caffeine, using the DPPH assay, indicated a mild antioxidant activity for 6-selenocaffeine, contrasting with caffeine, that exhibited no antioxidant activity under the same experimental conditions. Interestingly, whereas 6-selenocaffeine has revealed to have a low cytotoxic potential in both MCF10A and MCF-7 breast cells (24 h, up to 100 µM, MTT assay), a differential effect was observed when used in combination with the anticancer agents doxorubicin and oxaliplatin in MCF-7 breast cancer cells. The co-treatment of doxorubicin (1 µM) and 6-selenocaffeine (100 µM) resulted in a slight decrease in cellular viability when compared to doxorubicin (1 µM) alone. Conversely, the seleno-caffeine derivative at the same concentration markedly increased the viability of oxaliplatin (100 µM)-treated cells (p < 0.01). Overall, this work highlights an emerging methodology to synthesize organoselenium compounds and points out the differential roles of 6-selenocaffeine in the modulation of the cytotoxicity of anticancer agents.
Keywords: organoselenium compounds; caffeine; modulator of the cytoxicity; oxaliplatin; doxorubicin; cancer therapy

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Martins, I.L.; Miranda, J.P.; Oliveira, N.G.; Fernandes, A.S.; Gonçalves, S.; Antunes, A.M.M. Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells. Molecules 2013, 18, 5251-5264.

AMA Style

Martins IL, Miranda JP, Oliveira NG, Fernandes AS, Gonçalves S, Antunes AMM. Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells. Molecules. 2013; 18(5):5251-5264.

Chicago/Turabian Style

Martins, Inês L.; Miranda, Joana P.; Oliveira, Nuno G.; Fernandes, Ana S.; Gonçalves, Sandrina; Antunes, Alexandra M.M. 2013. "Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells." Molecules 18, no. 5: 5251-5264.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert